Hong Cen

Sugemalimab Monotherapy for Patients With Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma (GEMSTONE-201): Results From a Single-Arm, Multicenter, Phase II Study

Huiqiang Huang, Rong Tao, Siguo Hao et al. · Journal of Clinical Oncology · 2023 · 48 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial

Tingyu Wang, Xiuhua Sun, Lihua Qiu et al. · Clinical Cancer Research · 2023 · 38 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Preliminary Results from a Multicenter, Single-Arm, Phase 2 Study of CS1001, an Anti-Programmed Death-Ligand 1 (PD-L1) Human Monoclonal Antibody (mAb), in Patients (pts) with Relapsed or Refractory Extranodal Natural Killer/T Cell Lymphoma (rr-ENKTL)

Huiqiang Huang, Rong Tao, Liqun Zou et al. · Blood · 2019 · 17 citations

Life Sciences, Immunology, Oncology +17

A Phase Ib Study of Linperlisib in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-cell Lymphoma

Jie Jin, Hong Cen, Keshu Zhou et al. · Clinical Cancer Research · 2024 · 13 citations

Pharmacy, Pharmacology, Pharmacotherapy +17